Archives in Cancer Research

contact@imedpub.com Submit a Manuscript

Atypical Chronic Myelogenous Leukemia Research Articles

Incessant myelogenous leukemia (CML), otherwise called interminable myeloid leukemia, is a malignant growth of the white platelets. It is a type of leukemia described by the expanded and unregulated development of myeloid cells in the bone marrow and the collection of these cells in the blood. CML is a clonal bone marrow foundational microorganism issue in which an expansion of develop granulocytes (neutrophils, eosinophils and basophils) and their forerunners is found. It is a kind of myeloproliferative neoplasm related with a trademark chromosomal translocation called the Philadelphia chromosome. CML is to a great extent rewarded with focused medications called tyrosine-kinase inhibitors (TKIs) which have prompted drastically improved long haul endurance rates since 2001. These medications have upset treatment of this infection and permit most patients to have a decent personal satisfaction when contrasted with the previous chemotherapy drugs. In Western nations, CML represents 15–25% of every single grown-up leukemia and 14% of leukemias by and large (counting the pediatric populace, where CML is less normal).

High Impact List of Articles
Conference Proceedings

Relevant Topics in Oncology & Cancer Science

Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 193

Archives in Cancer Research received 193 citations as per Google Scholar report

image
Abstracted/Indexed in
  • Google Scholar
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs

View More »

Open Access Journals